克里斯蒂娜•杜兰

在我的职位上，我领导数字健康研究 & 开发(R&D) for three key focus areas: 肿瘤学; 心血管，肾脏和代谢; and 呼吸 and 免疫学. 澳门第一赌城在线娱乐的跨职能团队采取科学的, evidence-based approach – harnessing the power of artificial intelligence, data science and 数字 technology – to accelerate the delivery of new medicines to patients.

I have held senior leadership roles across global commercial, in-country commercial, finance and R&D in the eleven years that I have been with AstraZeneca. Most recently, I led a global transformation in clinical development across R&D functions, focusing on patients’ experience and outcomes.

Transforming patients’ experience and outcomes through the use of innovative technologies is what drives our Digital Health team. I am proud of our team’s work and dedication to our goals to accelerate the delivery of new medicines to patients, redefine clinical trials to be more patient centric using 数字 technologies that improve how clinical trials are run, and work with our global strategic partners to transform the entire patient journey—connecting prediction, 预防, management and treatment of patients more rapidly.

加入澳门在线赌城娱乐之前, I was a senior management consultant at Accenture, 领导大型转型计划, 包括成立一家新的合资企业, 从头开始, 两家科技公司之间, which is 现在是一家顶级零售商的主要业务, 指导业务转型战略审查, and implementing global change initiatives for large telecoms.

I am passionate about innovation and increasing enterprise value by inspiring organisations to change for the future, and have spoken about using innovative technologies to transform patient’s lives at conferences including the Digital Health World Congress and the Financial Times Global Pharmaceutical and Biotechnology Conference. I am a chartered accountant (CIMA) and have completed the Massachusetts Institute of Technology Leading Enterprise 转换 programme.